The use of combination vaccines has improved timeliness of vaccination in children

被引:139
作者
Kalies, Helen
Grote, Veit
Verstraeten, Thomas
Hessel, Luc
Schmitt, Heinz-Josef
von Kries, Ruediger
机构
[1] Univ Munich, Inst Social Pediat & Adolescent Med, Dept Pediat Epidemiol, D-81377 Munich, Germany
[2] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
[3] Galxo SmithKline Biol, Rixensart, Belgium
[4] Sanofi Pasteur MSD, Lyon, France
[5] Johannes Gutenberg Univ Mainz, D-6500 Mainz, Germany
关键词
combination vaccines; up-to-date immunization; Germany;
D O I
10.1097/01.inf.0000222413.47344.23
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: In Germany, Haemophilus influenzae type b (Hib), polio and hepatitis B (HBV) vaccines have been combined with diphtheria, tetanus and acellular pertussis vaccines. We examined whether the use of combination vaccines has improved the timing of these vaccinations. Methods: Vaccination information was obtained from representative nationwide telephone interviews about 2701 children born from 1996 through 2003 in Germany. We assessed up-to-date vaccination as the percentage of children vaccinated by 3, 5 and 15 months for the first dose, full primary series and full immunization, respectively. We compared results over periods when different combination vaccines were used. We also compared median age at first dose, full priming and full immunization for children receiving different types of combination vaccines. Results: During the study period, monovalent vaccines were replaced by higher-valent combination vaccines. With the change from mono- to 4-, 5- and 6-valent vaccines, up-to-date vaccination increased for Hib, polio and HBV. Median age at immunization improved by 0.5 month for Hib, 0.4 month for polio and 0.9 month for HBV at the first dose and 2.2 months for Hib, 3.2 months for polio and 1.4 months for HBV at full immunization when comparing hexavalent with monovalent vaccines. Median age for 4-5-valent vaccines was intermediate. The difference between monovalent and 6-valent vaccines remained significant after stratifying/adjusting for the effect of birth cohorts. Conclusion: Combination vaccines are usually advocated for reducing the number of injections. In Germany, however, the use of combination vaccines has also significantly improved timeliness of immunizations.
引用
收藏
页码:507 / 512
页数:6
相关论文
共 11 条
[1]  
Cox D. R., 1984, Analysis of survival data
[2]   How best to estimate the global burden of pertussis? [J].
Crowcroft, NS ;
Stein, C ;
Duclos, P ;
Birmingham, M .
LANCET INFECTIOUS DISEASES, 2003, 3 (07) :413-418
[3]   Immunisation status of children in Germany: temporal trends and regional differences [J].
Kalies, H ;
Grote, V ;
Schmitt, HJ ;
von Kries, R .
EUROPEAN JOURNAL OF PEDIATRICS, 2006, 165 (01) :30-36
[4]   Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Hoemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H-influenzae type b combination vaccines in Germany [J].
Kalies, H ;
Verstraeten, T ;
Grote, V ;
Meyer, N ;
Siedler, A ;
Schmitt, HJ ;
Breuer, T ;
Moulton, LH ;
von Kries, R .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (10) :944-950
[5]  
KIRSCHNER W, 1997, KINDERARZTL PRAX, P7
[6]  
KOCHINSTITUT R, 2003, EPIDEMIOL INFECT, V32, P243
[7]   Detection of delayed vaccinations: a new approach to visualize vaccine uptake [J].
Laubereau, B ;
Hermann, M ;
Schmitt, HJ ;
Weil, J ;
Von Kries, R .
EPIDEMIOLOGY AND INFECTION, 2002, 128 (02) :185-192
[8]  
Laubereau B, 2001, MONATSSCHR KINDERH, V149, P367, DOI 10.1007/s001120050777
[9]   Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century:: Global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates [J].
Peltola, H .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (02) :302-+
[10]   Haemophilus influenzae type b disease:: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H-influenzae type b combination vaccines [J].
Schmitt, HJ ;
Von Kries, R ;
Hassenpflug, B ;
Hermann, M ;
Siedler, A ;
Niessing, W ;
Clemens, R ;
Weil, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (08) :767-774